Zdrowie i gospodarka · 02/06/2023
FDA Announces Draft Guidance for Developing Migraine Preventive Drugs
The FDA has released a draft guidance document to help pharmaceutical companies develop drugs for preventing migraines, building on existing guidance for acute treatment.